•
AP
APM
Aptorum Group Limited Class A Ordinary Shares
yahoo--
Price Chart
Market Cap
7.98M
Volume
38.66K
52W High
$4.47
52W Low
$0.69
Open
$0.00
Prev Close
$1.02
Day Range
0.00 - 0.00
About Aptorum Group Limited Class A Ordinary Shares
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.
Latest News
DiamiR Biosciences and Aptorum Group Announce New York State Approval for DiamiR's APOE Genotyping Test
Benzinga•Aug 21
Aptorum Group Limited and DiamiR Biosciences Enter into Definitive Merger Agreement
Benzinga•Jul 16
Aptorum Group Limited Announces Pricing of $3.0 Million Registered Direct Offering
GlobeNewswire Inc.•Jan 2
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga•Mar 14
US Stocks Higher; Producer Prices Rise 0.6% In February
Benzinga•Mar 14
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga•Mar 7
Nasdaq Rises 100 Points; BJ's Wholesale Posts Weak Sales
Benzinga•Mar 7
Why Rush Street Interactive Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
Benzinga•Mar 7